Literature DB >> 16571788

Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex.

David J Dismuke1, Christopher Aiken.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) particles begin their replication upon fusion with the plasma membrane of target cells and release of the viral core into the host cell cytoplasm. Soon thereafter, the viral capsid, which is composed of a polymer of the CA protein, disassociates from the internal ribonucleoprotein complex. While this disassembly process remains poorly understood, the available evidence indicates that proper uncoating of the core is a key step in infection. Defects in uncoating most often lead to a failure of the virus to undergo reverse transcription, resulting in an inability to form a functional viral preintegration complex (PIC). In a previous study, we reported that an HIV-1 mutant containing two substitutions in CA (Q63A/67A) was unusual in that it was poorly infectious yet synthesized normal levels of viral DNA. Here we report that this mutant is impaired for nuclear entry. Quantitative analysis of viral DNA synthesis from infected cells by Southern blotting and real-time PCR revealed that the Q63A/Q67A mutant is impaired in the synthesis of one-long terminal repeat (1-LTR) and 2-LTR circles. Isolation of PICs from acutely infected cells revealed that the Q63A/Q67A mutant produces protein-DNA complexes similar to wild-type in yield and overall composition, but these PICs contained elevated levels of CA and were impaired for integration in vitro. These results demonstrate that mutations in CA can have deleterious effects on both nuclear targeting and integration, suggesting that these steps in the HIV-1 life cycle are dependent on proper uncoating of the viral core.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16571788      PMCID: PMC1440469          DOI: 10.1128/JVI.80.8.3712-3720.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  A quantitative assay for HIV DNA integration in vivo.

Authors:  S L Butler; M S Hansen; F D Bushman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity.

Authors:  N Chazal; G Singer; C Aiken; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  HIV-1 genome nuclear import is mediated by a central DNA flap.

Authors:  V Zennou; C Petit; D Guetard; U Nerhbass; L Montagnier; P Charneau
Journal:  Cell       Date:  2000-04-14       Impact factor: 41.582

Review 5.  Molecular biology of lentivirus-mediated gene transfer.

Authors:  M Stevenson
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

6.  HIV-1 infection requires a functional integrase NLS.

Authors:  M Bouyac-Bertoia; J D Dvorin; R A Fouchier; Y Jenkins; B E Meyer; L I Wu; M Emerman; M H Malim
Journal:  Mol Cell       Date:  2001-05       Impact factor: 17.970

7.  Multiple integrase functions are required to form the native structure of the human immunodeficiency virus type I intasome.

Authors:  H Chen; S Q Wei; A Engelman
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

8.  Structural requirements for recognition of the human immunodeficiency virus type 1 core during host restriction in owl monkey cells.

Authors:  Brett M Forshey; Jiong Shi; Christopher Aiken
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

9.  Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope.

Authors:  J Zhou; C Aiken
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

10.  Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

View more
  120 in total

1.  RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating.

Authors:  Amanda Roa; Fumiaki Hayashi; Yang Yang; Maritza Lienlaf; Jing Zhou; Jiong Shi; Satoru Watanabe; Takanori Kigawa; Shigeyuki Yokoyama; Christopher Aiken; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

2.  HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6.

Authors:  Kyeongeun Lee; Alok Mulky; Wendy Yuen; Thomas D Martin; Nicholas R Meyerson; Laura Choi; Hyun Yu; Sara L Sawyer; Vineet N Kewalramani
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 3.  HIV-1 assembly, budding, and maturation.

Authors:  Wesley I Sundquist; Hans-Georg Kräusslich
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 4.  Features, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function.

Authors:  Gilles Mirambeau; Sébastien Lyonnais; Robert J Gorelick
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 5.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

6.  Human immunodeficiency virus type 1 capsid mutation N74D alters cyclophilin A dependence and impairs macrophage infection.

Authors:  Zandrea Ambrose; KyeongEun Lee; Jean Ndjomou; Hongzhan Xu; Ilker Oztop; James Matous; Taichiro Takemura; Derya Unutmaz; Alan Engelman; Stephen H Hughes; Vineet N KewalRamani
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

7.  Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.

Authors:  María Pernas; Laura Tarancón-Diez; Cecilio Lopez-Galindez; Ezequiel Ruiz-Mateos; Esther Rodríguez-Gallego; Josep Gómez; Julia G Prado; Concepción Casado; Beatriz Dominguez-Molina; Isabel Olivares; Maite Coiras; Agathe León; Carmen Rodriguez; Jose Miguel Benito; Norma Rallón; Montserrat Plana; Onofre Martinez-Madrid; Marta Dapena; Jose Antonio Iribarren; Jorge Del Romero; Felipe García; José Alcamí; MaÁngeles Muñoz-Fernández; Francisco Vidal; Manuel Leal
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

8.  Quantitative analysis of HIV-1 preintegration complexes.

Authors:  Alan Engelman; Ilker Oztop; Nick Vandegraaff; Nidhanapati K Raghavendra
Journal:  Methods       Date:  2009-02-20       Impact factor: 3.608

9.  Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant.

Authors:  Chisu Song; Christopher Aiken
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

10.  Contribution of PDZD8 to stabilization of the human immunodeficiency virus type 1 capsid.

Authors:  Charles Alexander Guth; Joseph Sodroski
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.